Post-Doctoral Fellow

The Center for Precision Imaging at the Massachusetts General Hospital Martinos

Center/Harvard Medical School has openings for highly qualified individuals at the postdoctoral

level to work on PET molecular imaging probe/molecular therapeutics

(theranostics) development. Our Center is at the forefront of personalized imaging and

we are working to pioneer novel imaging and therapeutic agents for individualize

treatment of cancer. We have a long-standing interest in developing and translating

targeted biological PET probes for improved tumor characterization for personalizing

cancer treatment and autoimmune conditions. Over the past decade, we have

produced many PET and optical imaging probes for assessing immune system

activation, receptor imaging, imaging of the tumor microenvironment and interrogation of metabolome. Our group has led some of the first efforts to diagnose therapeutic

resistance through receptor imaging and feedback loop signaling, monitor and predict

the immune response in cancer immunotherapy and utilize targeted imaging to

determine effective therapy dosing, among others. These efforts have led to two first inhuman

imaging agents, most recently 68Ga-NOTA-hGZP for imaging granzyme B,

currently in open trials for clinical validation.

Successful candidate(s) should have a proven track record of continued

achievement and be self-motivated with strong work ethic, a commitment to teamwork

and effective communication skills. If you are interested, please contact the CPI using

the following email to umahmood@mgh.harvard.edu or directly applying to the position

here.

Strong background in biochemistry, peptide/protein engineering

Development of biological molecular probes, radiometals and/or

radiochemistry. Prior experience in cancer biology, cancer immunology and animal models of

disease is preferred.

Minimum requirement is a PhD or MD.